ArticleCancer science2013

MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy.

Eri Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.